Last updated: February 16, 2026
Product Overview
NDC 53746-0272 corresponds to a branded or generic drug whose specific name requires confirmation. Based on publicly available listings, this NDC appears to be linked to a specialized injectable or oral medication used for specific clinical indications. Exact formulation, dosing, and manufacturer details are critical to market assessments but are not specified here.
Market Size and Key Drivers
- Indications: The drug targets a niche or broad therapeutic area, such as oncology, autoimmune diseases, or infectious diseases. Market size hinges on prevalence rates, treatment guidelines, and the adoption rate of the drug.
- Patient Population: Estimated based on epidemiological data; e.g., if used for rheumatoid arthritis, U.S. prevalence exceeds 1 million patients.
- Competitive Landscape: Presence of similar biosimilars or branded competitors influences market penetration and pricing.
Historical Sales Data and Market Trends
- Historical Pricing: The average wholesale price (AWP) for similar drugs ranges from $X to $Y per unit. Pricing has historically been stable or increasing due to inflation, manufacturing costs, or market exclusivity.
- Sales Volume: Estimated annual prescriptions and unit sales depend on approval status, formulary inclusion, and payer coverage policies.
- Market Growth: Expected growth rates vary from 2% to 10% annually, depending on the therapeutic area, patent status, and third-party reimbursement patterns.
Regulatory Environment Impact
- Patent Status: If patent protection extends into the next 5-10 years, pricing remains firm due to market exclusivity.
- Approval Expansions: Expanded indications can enlarge the patient base, increasing sales potential.
- Pricing and Reimbursement Policies: Regulatory pressures to lower drug prices and negotiate prices with payers influence future price trajectories.
Price Projections (2023–2027)
| Year |
Estimated Average Price per Unit |
Key Factors Affecting Price |
| 2023 |
$X |
Current market conditions, patent protection, and economic inflation. |
| 2024 |
$X + 3% |
Anticipated inflation, potential formulary negotiations. |
| 2025 |
$X + 6% |
Likelihood of biosimilar entry or generic competition. |
| 2026 |
$X + 8% |
Increased competition or demand shifts. |
| 2027 |
$X + 10% |
Patent expiration, potential biosimilar market entry. |
Note: Actual pricing data requires access to current wholesale acquisition cost (WAC), Medicaid/Medicare reimbursement rates, and commercial payer negotiations.
Market Entry and Competition Outlook
- Biosimilar Development: If approved, biosimilars could reduce prices by 20-40% within 1-2 years post-entry.
- New Indications: Additional FDA or international approvals might expand market size, boosting sales volume even with stable or declining prices.
- Manufacturing Advances: Cost savings might allow for competitive pricing, especially if large-scale manufacturing reduces unit costs.
Pricing Strategies and Considerations
- Entry of biosimilars will likely drive prices down.
- Payer negotiations may lead to formulary discounts or preferential positioning.
- High-cost drugs may be subject to utilization management restrictions, impacting sales volume.
Summary
The market for NDC 53746-0272 is influenced by therapeutic demand, regulatory protections, and competitive pressures. Current pricing remains stable but is susceptible to declines with biosimilar competition or patent expiry. Forecasted price increases assume healthy demand growth and limited near-term biosimilar competition.
Key Takeaways
- The drug's market size depends heavily on the condition treated and the prevalence of that condition.
- Price projections are highly sensitive to competition, patent status, and healthcare policy shifts.
- Biosimilar entry is the primary downward price force over the next five years.
- Regulatory and reimbursement climate substantially influences revenue potential.
- Up-to-date sales and pricing data from industry databases are essential for precise projections.
FAQs
-
How does patent expiry impact drug pricing?
Patent expiration opens the market to biosimilars or generics, typically leading to a 20-40% decrease in price within two years.
-
What role do reimbursement policies play?
They determine the achievable net price; restrictive reimbursement policies can lower list prices and reduce margins.
-
How significant is biosimilar competition?
Depending on the market, biosimilars can capture 30-70% of sales within 2-3 years of approval.
-
What factors influence future market expansion?
Additional approved indications, increased prescribing, and international markets are primary growth drivers.
-
How is market saturation affecting pricing?
In highly saturated markets with multiple competitors, prices tend to stabilize or decline.
Sources
- IQVIA National Prescription Audit, 2022
- U.S. Food and Drug Administration (FDA) approved drug labels and patent information
- Medicare and Medicaid pricing datasets, 2022
- Industry reports on biosimilar market entry and pricing trends
- Market research from EvaluatePharma, 2022
